Table 1 Previously identified breast cancer survival genes in cancer-related pathways

DNA repair

XRCC1, XRCC2, XRCC3, RAD51B, LIG4, ERCC2

[6,28-32]

Cell cycle control

CCND1, CCND3, PRKAG2, TP53, SIPA1, FGFR2, PPP2R2B

[28,33-38]

Matrix metalloproteinases

MMP7, MMP8, MMP2, SERPINE1, TIMP-3

[23,40-44]

Immune and drug response, metabolism

Il-10, IL-6, IL-21, MPO, GSTP1, COMT, CYP19A1, CYP1A1, SULT1E1, NEF2L2, TLR4, SLC28A3, CD24, CD44, NQO1

[14,22,24,45-57]

Tumour progression

NOS3, VEGF, NME1, SELE, GNAS1, ZFP36, TGF

[58-64]

Vitamin D receptors

RXRA, VDR

[65,66]

Miscellaneous

TOX3, MTHFR, COX11, OCA2, PLAUR.

[4,7,34,65,67]